Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

45

Number of overlapping holdings

33.1%

% of XBI's 136 holdings also in BBP

73.8%

% of BBP's 65 holdings also in XBI

Overlap by Weight
Sector Drift (XBI minus BBP)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in XBI
Weight
in BBP
Overlap
ALNYLAM PHARMACEUTICALS INC 2.4% 2.1% 2.1%
GILEAD SCIENCES INC 2.8% 1.8% 1.8%
INSMED INC 2.5% 1.8% 1.8%
TG THERAPEUTICS INC 1.8% 1.8% 1.8%
UNITED THERAPEUTICS CORP 2.7% 1.7% 1.7%

Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to BBP
NATERA INC 3.3%
ADVENTRX PHARMACEUTICALS INC 2.5%
EXACT SCIENCES CORP 2.4%
ABBVIE INC 2.4%
VIKING THERAPEUTICS, INC. 2.0%
CYTOKINETICS INC 1.6%
REVOLUTION MEDICINES, INC. 1.4%
INCYTE CORP 1.3%
AVIDITY BIOSCIENCES INC 1.3%
ALKERMES PLC 1.1%
XBI Underweight Relative to BBP
LIGAND PHARMACEUTICALS-CL B -1.9%
LEXICON PHARMACEUTICALS, INC. -1.9%
LEGEND BIOTECH CORPORATION SPONSORED -1.9%
MIRUM PHARMACEUTICALS, INC. -1.8%
THERAVANCE BIOPHARMA INC -1.8%
TRAVERE THERAPEUTICS, INC. -1.7%
AXSOME THERAPEUTICS, INC. -1.7%
INTRA-CELLULAR THERAPIES INC -1.7%
HARMONY BIOSCIENCES HOLDINGS, INC. -1.7%
PHATHOM PHARMACEUTICALS, INC. -1.6%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY